Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
General reference information for laboratory and clinic staff. It is not medical advice and not a validation protocol.
Short answer
Bacillus atrophaeus is a spore-forming bacterium used as the test organism in biological indicators that monitor ethylene oxide (EtO) and dry-heat sterilization. FDA’s biological indicator guidance (October 4, 2007) recommends it for those two processes, and CDC names it the recommended biological indicator for EtO. Steam and hydrogen peroxide use a different organism.
Definition and scope
In sterilization monitoring, a biological indicator (BI) carries a known number of spores of a known resistance. Under 21 CFR 880.2800(a), a biological sterilization process indicator is a device intended for use by a health care provider to accompany products being sterilized; it contains a known number of microorganisms of known resistance to the sterilization mode, in a protective package, and growth or failure to grow indicates whether sterilization was adequate. FDA classifies it as Class II (product code FRC, “Indicator, Biological Sterilization Process”).
B. atrophaeus is the organism name FDA’s guidance uses today. The same guidance lists it as “formerly Bacillus subtilis var. niger“, so an older label, instructions for use or SOP that names B. subtilis var. niger refers to the organism now called B. atrophaeus.
How it is used in practice
CDC’s Guideline for Disinfection and Sterilization in Healthcare Facilities states that ethylene oxide inactivates all microorganisms, although bacterial spores, especially B. atrophaeus, are more resistant than other microorganisms, and that for this reason B. atrophaeus is the recommended biological indicator. CDC gives four operational ranges for EtO sterilization: gas concentration 450 to 1200 mg/l, temperature 37 to 63 °C, relative humidity 40 to 80%, and exposure time 1 to 6 hours.
FDA’s guidance describes how a BI is characterized: the manufacturer states the spore population and the D-value, the time at a given set of conditions needed to reduce the spore population by 90%. FDA gives the kill time as not more than the D-value multiplied by (log10 of the viable spore population + 4). One example row for EtO in the guidance (600 mg/L, 60% relative humidity, 54 °C) lists a spore population of 106 and a D-value of 3 minutes. It illustrates how cleared BIs are described; it is not a cycle recommendation.
FDA recommends 7 days as the conventional incubation time for BIs used to monitor the traditional sterilization processes in its Table 2; shorter incubation times need validation. Read the incubation time and organism on your own BI’s instructions for use rather than assuming it.
Which organism monitors which process
The table reproduces FDA’s Table 2, “Recommended Spores for Sterilization Process”, from the 2007 BI guidance.
| Sterilization process | Recommended spore (FDA Table 2) |
|---|---|
| Steam | Geobacillus stearothermophilus (formerly Bacillus stearothermophilus) |
| Dry heat | Bacillus atrophaeus (formerly Bacillus subtilis var. niger) |
| Ethylene oxide | Bacillus atrophaeus (formerly Bacillus subtilis var. niger) |
| Hydrogen peroxide | Geobacillus stearothermophilus |
For sterilization methods not on that list, FDA says the BI used for validation should be demonstrated to be the most resistant to the process.
Where it matters for labs and clinics
- Matching the BI to the process. A B. atrophaeus BI belongs with EtO or dry-heat loads; a steam autoclave or hydrogen peroxide system calls for the G. stearothermophilus organism in FDA’s table. See autoclave sterilization temperature and STERRAD hydrogen peroxide gas plasma sterilization for those processes.
- Reading labels and old documents. The name B. subtilis var. niger on an older record maps to B. atrophaeus.
- Validation context. BIs are one part of a validated process; see sterilization validation across steam, EtO and radiation, low-temperature sterilization method selection and dry-heat sterilizer vs autoclave.
- Other monitoring tools. Biological indicators sit alongside chemical indicators; see chemical indicators for sterilization, helix test and sterility assurance level, and log reduction and D-value for the arithmetic.
Common misunderstandings
- “It is the standard autoclave spore.” No. FDA’s Table 2 assigns steam to Geobacillus stearothermophilus.
- “A different name means a different organism.” B. subtilis var. niger is the former name used in FDA’s table for B. atrophaeus.
- “The same spore monitors every process.” FDA recommends different organisms by process, and for processes not listed the BI must be shown to be the most resistant to that process.
- “The incubation time is whatever the lab prefers.” FDA treats 7 days as the conventional time and requires validation for shorter times.
FAQ
What is Bacillus atrophaeus used for in sterilization?
It is the test spore in biological indicators for ethylene oxide and dry-heat sterilization, per FDA’s 2007 BI guidance, and CDC calls it the recommended biological indicator for EtO.
What was Bacillus atrophaeus formerly called?
FDA’s guidance lists it as formerly Bacillus subtilis var. niger.
Is a biological indicator regulated as a medical device?
Yes. 21 CFR 880.2800 defines the biological sterilization process indicator and classifies it as Class II.
Sources
- CDC, Guideline for Disinfection and Sterilization in Healthcare Facilities, ethylene oxide sterilization page: https://www.cdc.gov/infection-control/hcp/disinfection-sterilization/ethylene-oxide-sterilization.html (checked 2026-10-30).
- FDA, Biological Indicator (BI) Premarket Notification [510(k)] Submissions, guidance issued October 4, 2007: https://www.fda.gov/media/71134/download (checked 2026-10-30).
- 21 CFR 880.2800, Sterilization process indicator: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-880/subpart-C/section-880.2800 (checked 2026-10-30); FDA product classification code FRC via openFDA (checked 2026-10-30).







